Vishay Intertechnology Announces Amended and Restated $640

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Vishay Intertechnology Announces Amended and Restated $640 Million Credit Facility

MALVERN, Pa., Dec. 10, 2015 (GLOBE NEWSWIRE) -- Vishay Intertechnology, Inc. (NYSE: VSH ) today announced that it has entered into an amended and restated $640 million credit facility.  The senior secured facility matures on December 10, 2020.  The Company’s previous credit agreement was scheduled to mature on August 8, 2018. 

Borrowings under the Amended and Restated Credit Facility bear interest at LIBOR plus an interest margin. The applicable interest margin is based on Vishay's leverage ratio.  Based on Vishay's current leverage ratio, borrowings bear interest at LIBOR plus 1.75%.  Vishay also pays a fee, also based on its leverage ratio, on undrawn amounts.   The undrawn commitment fee, based on Vishay’s current leverage ratio, is 0.35% per annum.  The previous credit agreement required Vishay to pay facility fees on the entire commitment amount.

The Amended and Restated Credit Facility allows an unlimited amount of defined “Restricted Payments,” which include cash dividends and share repurchases, provided the Company’s pro forma leverage ratio is less than 2.25 to 1.  If the Company’s leverage ratio is greater than 2.25 to 1, the Amended and Restated Credit Facility allows such payments up to $75 million per annum (subject to a cap of $225 million for the term of the facility).

The Amended and Restated Credit Facility also removes certain restrictions related to intercompany transactions.  These changes are expected to enable the Company to streamline its complex subsidiary structure and provide greater operating flexibility.

Except for the term, pricing, and certain covenants, the amended and restated credit facility is substantially similar to the previous credit agreement.

Lori Lipcaman, Vishay’s Chief Financial Officer said, “We are pleased that we were able to extend our credit facility, while also reducing our cost and improving our financial flexibility.”

JPMorgan Chase Bank, N.A. acted as administrative agent. J.P. Morgan Securities LLC, Comerica Securities, Inc., Citizens Bank, N.A., and HSBC Bank USA, National Association served as joint lead arrangers and joint bookrunners.  J.P. Morgan Securities LLC, Comerica Bank, Citizens Bank N.A., and HSBC Bank USA, National Association served as co-syndication agents.  UniCredit Bank AG, New York Branch functioned as documentation agent.

Forward-Looking Statements

Statements contained herein that relate to the Company's future performance, including statements with respect to financing arrangements and the Company’s structure and operations are forward-looking statements within the safe harbor provisions of Private Securities Litigation Reform Act of 1995. Words such as “believe,” “estimate,” “will be,” “will,” “would,” “expect,” “anticipate,” “plan,” “project,” “intend,” “could,” “should,” or other similar words or expressions often identify forward-looking statements. Such statements are based on current expectations only, and are subject to certain risks, uncertainties and assumptions, many of which are beyond our control. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results, performance, or achievements may vary materially from those anticipated, estimated or projected. Among the factors that could cause actual results to materially differ include: general business and economic conditions; difficulties in implementing our cost reduction and restructuring strategies; changes in foreign currency exchange rates; competition and technological changes in our industries; difficulties in new product development; difficulties in identifying suitable acquisition candidates, consummating a transaction on terms which we consider acceptable, and integration and performance of acquired businesses; uncertainty related to the effects of changes in foreign currency exchange rates; and other factors affecting our operations that are set forth in our filings with the Securities and Exchange Commission, including our annual reports on Form 10-K and our quarterly reports on Form 10-Q. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Vishay Intertechnology, Inc., a Fortune 1,000 Company listed on the NYSE (VSH), is one of the world's largest manufacturers of discrete semiconductors (diodes, MOSFETs, and infrared optoelectronics) and passive electronic components (resistors, inductors, and capacitors). These components are used in virtually all types of electronic devices and equipment, in the industrial, computing, automotive, consumer, telecommunications, military, aerospace, power supplies, and medical markets. Vishay’s product innovations, successful acquisition strategy, and "one-stop shop" service have made it a global industry leader. Vishay can be found on the Internet at  http://www.vishay.com .

CONTACT: Contact: Vishay Intertechnology, Inc. Peter G. Henrici Senior Vice President, Corporate Communications +1-610-644-1300

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CatsOnly: Building Community with Feline-Centric Care

Updated Category News Views 36

Cats Only: Not Just Another Vet Office Sometimes, a new kind of passion-driven initiative gets your attention. That's where CatsOnly™ steps in—a feline-exclusive clinic that’s not about the bottom line but about building connections and elevating that ultimate feline care game. Their latest gig, dubbed Ginger’s Giving Season, is all about bridging the gap between...

Continue Reading
Paulex Bio's Grant Fuels Bold Diabetes Research Push

Updated Category News Views 94

Cracking the Diabetes Code: A New Hope Emerging It ain't every day you hear about a biotech outfit snagging an NIH Fast-Track grant with the potential to upend diabetes treatment, but Paulex Bio's recent score turns heads. Their brainchild, PAL-119, promises to tackle diabetes not by slapping a band-aid on symptoms, but by getting to the rotten core of the disease: the...

Continue Reading
Kia's Landmark Triple Win at 2026 Car Awards

Updated Category News Views 85

Kia Makes History Well, folks, Kia has pulled off what many might have thought impossible. They snagged not one, not two, but three of Germany's Golden Steering Wheel awards. That's a real hat trick and a first for any non-European auto brand. With competition hotter than a stolen Tesla, Kia's not just keeping pace but setting it. The Golden Steering Wheel is one of those...

Continue Reading
Resideo's AI-Powered Pro-IQ™ Predict: HVAC Revolution

Updated Category News Views 314

Is AI the Savior for HVAC Breakdowns? You ever been stuck on a freezing night with a busted heater? It's a classic tale: equipment goes south just when you need it most. But what if someone told you AI could catch HVAC issues before they send you running for the wool socks? Enter Resideo Technologies' latest brainchild, Pro-IQ™ Predict. This isn't some run-of-the-mill...

Continue Reading
Florida's Insurance Premiums: Why They Keep Skyrocketing

Updated Category News Views 61

What’s Driving Up These Premiums? If you’ve ever felt like your wallet gets lighter every time you pay your insurance premium, welcome to the club. It seems like the cost of insurance in Florida is like a runaway train. But don't just blame the hurricanes. Yeah, they definitely play their part, but there’s a bigger picture lurking behind those price tags. Weather...

Continue Reading
Dixie Group Gears Up for Q3 Earnings Call Reveal

Updated Category News Views 165

Anticipation Builds for The Dixie Group's Q3 Results Ah, the smell of anticipation in the air—it's earnings season again, folks! For those keeping a keen eye, The Dixie Group, Inc. (OTCQB: DXYN) sets the stage for the big unveil of its 2026 third-quarter results. They're rolling out the red carpet for investors on Thursday, November 12, 2026, at 11:30 a.m. Eastern Time,...

Continue Reading
Ceipal Ora: AI Revolution for Staffing Firms Begins

Updated Category News Views 65

Staffing Game Changer: Enter Ceipal Ora Folks in the staffing arena, hold onto your hats—Ceipal's rolling out something that could turn the tables. This new AI hotshot, Ceipal Ora, claims to be not just another AI patch on an old coat but the whole new garment itself. It's not just some afterthought glued to a platform; it's the glue holding the operations together,...

Continue Reading
CeQur Revolutionizes Insulin Delivery with Wearable Patch

Updated Category News Views 67

A Patch to Simplify Mealtime Insulin So, it turns out CeQur is stepping up to the plate with their new wearable insulin patch called CeQur Simplicity. They just rolled it out nationally, and it's not your grandmother's insulin delivery method—this one sticks around for a whole week with some nifty up-to-1-unit dosing. If you're shoving insulin needles or pens into your...

Continue Reading
Yeastar 2026 Summit: AI, Growth, and Global Vision

Updated Category News Views 32

Reflecting on Two Decades of Innovation Yeastar's 20th anniversary summit in Xiamen was no ordinary gathering. It wasn't just about handshakes and business cards. Nope, it was a celebration intertwined with a deeper vision of growth and influence in the UCaaS space that Yeastar has carved out for itself over the years. Here's a company that's been plotting its course for...

Continue Reading
Otus Earns Top Spot in Education AI at Innovation Awards

Updated Category News Views 85

Acknowledging AI's Growing Role in Education Times are changing, and the classroom ain't what it used to be. Enter Otus, a platform that's breaking the mold by bringing artificial intelligence smack dab into K-12 education. They've bagged the 2026 SmartBrief Innovation Award in AI within the Education category. Clocking in at serving nearly 100 school districts, it's...

Continue Reading

Top 5 Most Recently Viewed Articles

Revolutionizing Canine Cancer Treatment Through Innovation

Updated Category News Views 167

Revolutionizing Canine Cancer Care Through Innovation The world of veterinary medicine has seen incredible progress in caring for dogs with cancer. Thrive Pet Healthcare is making significant efforts to improve the quality of care for these pets. Their partnership with FidoCure, a leader in canine oncology, highlights their dedication to helping pet owners access...

Continue Reading
BioAtla to Showcase Innovative Cancer Therapies at Major Events

Updated Category News Views 189

BioAtla to Showcase Innovative Cancer Therapies at Major Events BioAtla, Inc. (Nasdaq: BCAB), a prominent player in the biotechnology sector, focuses on advancing Conditionally Active Biologic (CAB) antibody therapeutics aimed at treating solid tumors. With a commitment to innovation and patient care, the company announced that two of its research abstracts have been...

Continue Reading
Liberty Star Minerals' Geophysical Breakthrough in Gold Discovery

Updated Category News Views 158

Revelation in Gold Exploration Liberty Star Minerals, an innovative exploration company, has recently made headlines with the successful induced polarization (IP) and resistivity testing at the Red Rock Canyon Gold Project. This project is a part of their extensive Hay Mountain Project in southeastern Arizona. These tests are pivotal in the ongoing search for strategic...

Continue Reading
Malibu Boats Celebrates Another Award for the Wakesetter 23 LSV

Updated Category News Views 135

Malibu Boats Wakesetter 23 LSV Triumphs Again Malibu Boats, Inc. (NASDAQ: MBUU) continues to solidify its position as the leader in the watersports boating industry. The iconic Malibu Wakesetter 23 LSV has been awarded the prestigious title of Wakesurf and Wakeboard Boat of the Year for the sixth consecutive year by the WakeWorld Riders Choice Awards. This remarkable...

Continue Reading
Alto Neuroscience Faces Deadline for Securities Fraud Lawsuit

Updated Category News Views 100

Understanding Alto Neuroscience's Legal Challenges Alto Neuroscience, Inc. (NYSE: ANRO) is currently in the spotlight due to a securities fraud class action lawsuit filed on behalf of its investors. The company has faced scrutiny regarding its initial public offering (IPO) and claims that misrepresentations were made about its flagship product, ALTO-100, a treatment...

Continue Reading